SCHEMBL29909031

SCHEMBL29909031

Cc1ccc(-c2cccc(N(C)c3nc4nncn4c4cc(Br)ccc34)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.33
NPSR1 Q6W5P4 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
GAA P10253 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
EGFR P00533 4/20 0.33
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
PDGFRB P09619 2/20 0.32
DHODH Q02127 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23576865 1.00 MAPT (0.33) MAPTNPSR1KDM4EMEN1NPC1
SCHEMBL23576628 0.93 ABCG2 (0.38) MAPTKDM4EGABRA1GABRG2GABRB3
SCHEMBL29909102 0.93 ABCG2 (0.38) MAPTKDM4EGABRA1GABRG2GABRB3
SCHEMBL29909127 0.91 FNTA (0.36) MAPTSMN1; SMN2GABRA1GABRG2GABRB3
SCHEMBL23577060 0.91 FNTA (0.36) MAPTSMN1; SMN2GABRA1GABRG2GABRB3
SCHEMBL23576643 0.89 NPM1 (0.39) MAPTSMN1; SMN2GABRG2GABRB3GABRA5
SCHEMBL29909114 0.89 NPM1 (0.39) MAPTSMN1; SMN2GABRG2GABRB3GABRA5
SCHEMBL23576713 0.89 OPRD1 (0.34) MAPTSMN1; SMN2GABRA1GABRG2GABRB3
SCHEMBL29909719 0.89 OPRD1 (0.34) MAPTSMN1; SMN2GABRA1GABRG2GABRB3
SCHEMBL23576893 0.88 MAPT (0.33) MAPTKDM4EMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4445902-A2 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2024-10-16 EP disclosed
US-12054490-B2 Diacylglycerol kinase modulating compounds GILEAD SCIENCES, INC. (US) 2024-08-06 US disclosed
EP-4081305-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2022-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12054490-B2 Diacylglycerol kinase modulating compounds DGKG, DGKB, DGKK MAPT 4206/4885NPSR1 4250/4885KDM4E 1748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.